Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

47.36
Delayed Data
As of Jul 22
 +0.77 / +1.65%
Today’s Change
14.70
Today|||52-Week Range
50.11
+14.12%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close46.59
Today’s open46.42
Day’s range45.85 - 47.60
Volume346,017
Average volume (3 months)590,634
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-123.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,874.94%
P/E ratio5.2
Price/Sales2.95
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...+0.81+2.41%
AXONAxovant Sciences Ltd+0.85+6.39%
RLYPRelypsa Inc+0.12+0.38%
HALOHalozyme Therapeutic...-0.11-1.18%
Data as of 4:00pm ET, 07/22/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$379.8M
Annual profit (last year)$249.6M
Net profit margin65.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Financial Officer &
Senior Vice President
Marc L. Belsky
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs